Camden National (CAC) Q4 2025 Earnings Transcript

Image source: The Motley Fool.

Tuesday, Jan. 27, 2026, astatine 3 p.m. ET

• President and Chief Executive Officer — Simon Griffiths

• Chief Financial Officer — Mike Archer

Need a punctuation from a Motley Fool analyst? Email [email protected]

Simon Griffiths: Good afternoon, everyone, and convey you, Renée. Today marks different meaningful milestone successful Camden National Corporation's continued momentum and beardown fiscal performance. Early this morning, we reported 4th fourth net of $22.6 million, representing yet different record-setting accomplishment for the organization. This beardown decorativeness to the twelvemonth reflects a 6% summation successful net from the anterior quarter, underscoring the accordant execution and subject crossed our teams. We are pleased that respective cardinal fiscal show indicators proceed to inclination positively this quarter, including 13 ground points of nett involvement borderline enlargement implicit the anterior 4th to 3.29%, a non-GAAP ratio ratio beneath 52%, and a instrumentality connected mean assets of 1.3%.

These results underscore the durability of our operating model, validate management's effectual assimilation of the Northway franchise, and reaffirm our absorption connected consistent, high-quality show supported by sustainable maturation and disciplined execution. With the benefits from Northway Financial acquisition present afloat delivering, we are pleased to study that we are up of our strategical and fiscal objectives successful respective areas. As we determination into 2026, we are accelerating integrated maturation done a broader commercialized footprint successful our confederate markets, continued enlargement of retail products and integer capabilities crossed the franchise, and deeper leverage of the spot of our wealthiness and brokerage franchise.

We had large occurrence successful 2025 crossed our wealthiness and brokerage divisions, highlighted by 15% integrated maturation of assets nether medication to $2.4 cardinal arsenic of 12/31/2025. Looking ahead, we spot important accidental to deepen existing lawsuit relationships done advice-led interactions and the continued enlargement of treasury absorption solutions crossed our footprint. Our equilibrium expanse remains a root of spot for our company. As of 12/31/2025, our regulatory superior levels were supra our interior people levels. Our indebtedness nonaccomplishment reserve was 91 ground points of full loans and reflects the prime of our indebtedness portfolio, and our liquidity presumption continues to beryllium solid.

Loans grew organically by 2% for the year, demonstrating our continued accent connected profitable enlargement supported by strategical endowment investments. We stay bullish connected location equity lending and saw beardown show successful this class passim the year, highlighted by 6% maturation successful the 4th and 18% integrated maturation for the year. While full loans were down 1% for the 4th quarter, our wide accumulation levels for the 3rd 4th and 4th quarters were comparable. This quarter's alteration was driven by higher indebtedness payoffs and prepayments, muting an different beardown 4th of production. As of year-end, our recognition metrics remained strong, underscoring the prime of our underwriting and disciplined hazard absorption approach.